123 related articles for article (PubMed ID: 1961133)
1. Neuroblastoma stage IV-S: a heterogeneous disease.
Wilson PC; Coppes MJ; Solh H; Chan HS; Jenkin D; Greenberg ML; Weitzman S
Med Pediatr Oncol; 1991; 19(6):467-72. PubMed ID: 1961133
[TBL] [Abstract][Full Text] [Related]
2. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract][Full Text] [Related]
3. Features and outcome of neuroblastoma detected before birth.
Granata C; Fagnani AM; Gambini C; Boglino C; Bagnulo S; Cecchetto G; Federici S; Inserra A; Michelazzi A; Riccipetitoni G; Rizzo A; Tamaro P; Jasonni V; De Bernardi B
J Pediatr Surg; 2000 Jan; 35(1):88-91. PubMed ID: 10646781
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of biological factors in a recurrent IV-S neuroblastoma with intermediate-grade malignancy.
Ikeda H; Nagashima K; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M; Hirato J
J Pediatr Surg; 1995 Jun; 30(6):866-9. PubMed ID: 7666325
[TBL] [Abstract][Full Text] [Related]
5. Stage IV neuroblastoma in infants. Long-term survival.
Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
[TBL] [Abstract][Full Text] [Related]
6. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
[TBL] [Abstract][Full Text] [Related]
7. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital.
Mehdiabadi GB; Arab E; Rafsanjani KA; Ansari S; Moinzadeh AM
Asian Pac J Cancer Prev; 2013; 14(5):2739-42. PubMed ID: 23803024
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
[TBL] [Abstract][Full Text] [Related]
10. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract][Full Text] [Related]
11. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
[TBL] [Abstract][Full Text] [Related]
12. Prenatally diagnosed neuroblastoma.
Acharya S; Jayabose S; Kogan SJ; Tugal O; Beneck D; Leslie D; Slim M
Cancer; 1997 Jul; 80(2):304-10. PubMed ID: 9217044
[TBL] [Abstract][Full Text] [Related]
13. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
14. Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: an analysis of 37 patients.
Martinez DA; King DR; Ginn-Pease ME; Haase GM; Wiener ES
J Pediatr Surg; 1992 Aug; 27(8):1016-20; discussion 1020-1. PubMed ID: 1403526
[TBL] [Abstract][Full Text] [Related]
15. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course?
Guglielmi M; De Bernardi B; Rizzo A; Federici S; Boglino C; Siracusa F; Leggio A; Cozzi F; Cecchetto G; Musi L; Bardini T; Fagnani AM; Bartoli GC; Pampaloni A; Rogers D; Conte M; Milanaccio C; Bruzzi P
J Clin Oncol; 1996 May; 14(5):1537-44. PubMed ID: 8622069
[TBL] [Abstract][Full Text] [Related]
16. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma in children: a 10-year experience in Saudi Arabia.
al-Mulhim I
J Trop Pediatr; 1998 Apr; 44(2):77-80. PubMed ID: 9604593
[TBL] [Abstract][Full Text] [Related]
18. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987.
Suarez A; Hartmann O; Vassal G; Giron A; Habrand JL; Valteau D; Brugieres L; Kalifa C; Lemerle J
Med Pediatr Oncol; 1991; 19(6):473-7. PubMed ID: 1961134
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
